Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q2 2018 (← Previous) (Next →)
Filing Date: Aug 14, 2018
Total Value: $1.05B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | FIBROGEN INC | 2,017,250 | $126M | 12.0% | $36.02 | — | COM | 31572Q808 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 6,250,073 | $120M | 11.4% | $11.88 | +24.6% | COM | 46333X108 |
| — | ASSEMBLY BIOSCIENCES INC | 2,943,164 | $115M | 11.0% | $8.38 | — | COM | 045396108 |
| ASND | ASCENDIS PHARMA A S | 1,464,067 | $97.39M | 9.3% | $26.79 | — | SPONSORED ADR | 04351P101 |
| KURA | KURA ONCOLOGY INC | 3,904,675 | $71.06M | 6.8% | $10.03 | +68.8% | COM | 50127T109 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 199,500 | $55.8M | 5.3% | $175.60 | 0.0% | COM | 558868105 |
| — | CELGENE CORP | 585,000 | $46.46M | 4.4% | — | — | Call | 151020904 |
| SRRK | SCHOLAR ROCK HLDG CORP | 2,671,161 | $41.67M | 4.0% | $18.88 | 0.0% | COM | 80706P103 |
| — | DICERNA PHARMACEUTICALS INC | 2,961,147 | $36.27M | 3.5% | $7.99 | — | COM | 253031108 |
| MGNX | MACROGENICS INC | 1,450,606 | $29.95M | 2.9% | $19.87 | +13.4% | COM | 556099109 |
| — | ASCENDIS PHARMA A S | 447,000 | $29.73M | 2.8% | — | — | Call | 04351P901 |
| RCUS | ARCUS BIOSCIENCES INC | 2,236,387 | $27.37M | 2.6% | $16.66 | -5.8% | COM | 03969F109 |
| — | UNITY BIOTECHNOLOGY INC | 1,680,644 | $25.31M | 2.4% | $15.06 | — | COM | 91381U101 |
| — | KEZAR LIFE SCIENCES INC | 1,272,198 | $22.01M | 2.1% | $17.30 | — | COM | 49372L100 |
| — | FIBROGEN INC | 350,000 | $21.91M | 2.1% | — | — | Call | 31572Q908 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,509,671 | $21.44M | 2.0% | $16.61 | 0.0% | COM | 800677106 |
| — | MAGENTA THERAPEUTICS INC | 1,538,088 | $20.76M | 2.0% | $13.50 | — | COM | 55910K108 |
| — | GILEAD SCIENCES INC | 292,600 | $20.73M | 2.0% | — | — | Call | 375558903 |
| — | IMMUNE DESIGN CORP | 4,437,600 | $20.19M | 1.9% | $3.77 | — | COM | 45252L103 |
| WVE | WAVE LIFE SCIENCES LTD | 412,871 | $15.79M | 1.5% | $30.27 | +42.2% | COM | Y95308105 |
| — | SURFACE ONCOLOGY INC | 890,808 | $14.53M | 1.4% | $16.31 | — | COM | 86877M209 |
| — | EIGER BIOPHARMACEUTICALS INC | 1,039,500 | $12.68M | 1.2% | $12.20 | — | COM | 28249U105 |
| — | IRONWOOD PHARMACEUTICALS INC | 577,600 | $11.04M | 1.1% | — | — | Call | 46333X908 |
| — | ACHILLION PHARMACEUTICALS INC | 3,887,407 | $11M | 1.0% | $3.26 | — | COM | 00448Q201 |
| — | KADMON HLDGS INC | 2,500,000 | $9.975M | 0.9% | $3.99 | — | COM | 48283N106 |
| — | ASSEMBLY BIOSCIENCES INC | 148,100 | $5.807M | 0.6% | — | — | Call | 045396908 |
| — | DBV TECHNOLOGIES S A | 298,100 | $5.75M | 0.5% | $23.07 | — | SPONSORED ADR | 23306J101 |
| CRVS | CORVUS PHARMACEUTICALS INC | 450,400 | $4.945M | 0.5% | $11.04 | +1.2% | COM | 221015100 |
| — | AQUINOX PHARMACEUTICALS INC | 1,150,000 | $3.048M | 0.3% | $2.65 | — | COM | 03842B101 |
| — | ONCONOVA THERAPEUTICS INC | 7,500,000 | $3.034M | 0.3% | $0.40 | — | COM | 68232V306 |
| — | ERYTECH PHARMA | 153,964 | $1.734M | 0.2% | $11.26 | — | SPONSORED ADR | 29604W108 |
| — | APTINYX INC | 41,037 | $992K | 0.1% | $24.17 | — | COM | 03836N103 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 412,000 | $787K | 0.1% | $2.02 | 0.0% | COM | 45665G303 |